🎉 M&A multiples are live!
Check it out!

Bayer Valuation Multiples

Discover revenue and EBITDA valuation multiples for Bayer and similar public comparables like Pharming, Galapagos, and Vivoryon Therapeutics.

Bayer Overview

About Bayer

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.


Founded

1863

HQ

Germany
Employees

92.8K+

Website

bayer.com

Financials

LTM Revenue $54.4B

LTM EBITDA $11.4B

EV

$70.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Bayer Financials

Bayer has a last 12-month revenue (LTM) of $54.4B and a last 12-month EBITDA of $11.4B.

In the most recent fiscal year, Bayer achieved revenue of $54.9B and an EBITDA of $10.4B.

Bayer expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Bayer valuation multiples based on analyst estimates

Bayer P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $54.4B XXX $54.9B XXX XXX XXX
Gross Profit $29.8B XXX $29.8B XXX XXX XXX
Gross Margin 55% XXX 54% XXX XXX XXX
EBITDA $11.4B XXX $10.4B XXX XXX XXX
EBITDA Margin 21% XXX 19% XXX XXX XXX
EBIT $7.6B XXX $3.9B XXX XXX XXX
EBIT Margin 14% XXX 7% XXX XXX XXX
Net Profit $5.4B XXX -$3.0B XXX XXX XXX
Net Margin 10% XXX -5% XXX XXX XXX
Net Debt XXX XXX $39.2B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Bayer Stock Performance

As of July 11, 2025, Bayer's stock price is EUR 27 (or $32).

Bayer has current market cap of EUR 26.9B (or $31.6B), and EV of EUR 59.5B (or $70.1B).

See Bayer trading valuation data

Bayer Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$70.1B $31.6B XXX XXX XXX XXX $5.54

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Bayer Valuation Multiples

As of July 11, 2025, Bayer has market cap of $31.6B and EV of $70.1B.

Bayer's trades at 1.3x EV/Revenue multiple, and 6.8x EV/EBITDA.

Equity research analysts estimate Bayer's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Bayer has a P/E ratio of 5.9x.

See valuation multiples for Bayer and 12K+ public comps

Bayer Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $31.6B XXX $31.6B XXX XXX XXX
EV (current) $70.1B XXX $70.1B XXX XXX XXX
EV/Revenue 1.3x XXX 1.3x XXX XXX XXX
EV/EBITDA 6.1x XXX 6.8x XXX XXX XXX
EV/EBIT 9.2x XXX 17.9x XXX XXX XXX
EV/Gross Profit 2.4x XXX n/a XXX XXX XXX
P/E 5.9x XXX -10.5x XXX XXX XXX
EV/FCF 20.8x XXX 13.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Bayer Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Bayer Margins & Growth Rates

Bayer's last 12 month revenue growth is 0%

Bayer's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.

Bayer's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bayer's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Bayer and other 12K+ public comps

Bayer Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 0% XXX 0% XXX XXX XXX
EBITDA Margin 21% XXX 19% XXX XXX XXX
EBITDA Growth -2% XXX -6% XXX XXX XXX
Rule of 40 22% XXX 19% XXX XXX XXX
Bessemer Rule of X XXX XXX 21% XXX XXX XXX
Revenue per Employee XXX XXX $0.6M XXX XXX XXX
Opex per Employee XXX XXX $0.3M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 29% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 13% XXX XXX XXX
Opex to Revenue XXX XXX 47% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Bayer Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Agriculture comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Bayer M&A and Investment Activity

Bayer acquired  XXX companies to date.

Last acquisition by Bayer was  XXXXXXXX, XXXXX XXXXX XXXXXX . Bayer acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Bayer

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Bayer

When was Bayer founded? Bayer was founded in 1863.
Where is Bayer headquartered? Bayer is headquartered in Germany.
How many employees does Bayer have? As of today, Bayer has 92.8K+ employees.
Is Bayer publicy listed? Yes, Bayer is a public company listed on ETR.
What is the stock symbol of Bayer? Bayer trades under BAYN ticker.
When did Bayer go public? Bayer went public in 1953.
Who are competitors of Bayer? Similar companies to Bayer include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Bayer? Bayer's current market cap is $31.6B
What is the current revenue of Bayer? Bayer's last 12 months revenue is $54.4B.
What is the current revenue growth of Bayer? Bayer revenue growth (NTM/LTM) is 0%.
What is the current EV/Revenue multiple of Bayer? Current revenue multiple of Bayer is 1.3x.
Is Bayer profitable? Yes, Bayer is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Bayer? Bayer's last 12 months EBITDA is $11.4B.
What is Bayer's EBITDA margin? Bayer's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Bayer? Current EBITDA multiple of Bayer is 6.1x.
What is the current FCF of Bayer? Bayer's last 12 months FCF is $3.4B.
What is Bayer's FCF margin? Bayer's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Bayer? Current FCF multiple of Bayer is 20.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.